New Science Ventures is a Connecticut and London-based venture capital firm investing in early and late-stage companies using novel scientific approaches in the life sciences and information technology sectors. The firm backs companies addressing significant unmet needs with breakthrough science and technology. NSV's portfolio spans genomics, satellite technology, graphene electronics, customer data platforms, and biotechnology. Portfolio companies include Zeotap, PlanetiQ, Paragraf, biomodal, Trellis Bioscience, Achronix Semiconductor, and Antevia Networks, reflecting a focus on deep-tech innovation across both sectors.

Profile auto-generated from public sources — details unverified.